1. Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression Arch Gen Psychiatry. 2010;67(12):1256-1264. doi:10.1001/archgenpsychiatry.2010.168 Study flow of patients from screening to analysis. MBCT indicates mindfulness-based cognitive therapy; MDD, major depressive disorder; OHIP, Ontario Health Insurance Plan; and SCID, Structured Clinical Interview for DSM-IV. Figure Legend:

2. Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression Arch Gen Psychiatry. 2010;67(12):1256-1264. doi:10.1001/archgenpsychiatry.2010.168 Cumulative proportion of unstable remitters who survived without relapse during maintenance/follow-up. M-ADM indicates maintenance antidepressant monotherapy; MBCT, mindfulness-based cognitive therapy; and Pla + Clin, placebo plus clinical management. Figure Legend:

3. Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression Arch Gen Psychiatry. 2010;67(12):1256-1264. doi:10.1001/archgenpsychiatry.2010.168 Cumulative proportion of stable remitters who survived without relapse during maintenance/follow-up. M-ADM indicates maintenance antidepressant monotherapy; MBCT, mindfulness-based cognitive therapy; and Pla + Clin, placebo plus clinical management. Figure Legend: